West Pharma (WST) Tops Q1 EPS by 33c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $340.41 --0%
EPS Growth %: +13.0%
Financial Fact:
Cost of goods and services sold: 255.6M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +13.0%
Financial Fact:
Cost of goods and services sold: 255.6M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q1 EPS of $1.98, $0.33 better than the analyst estimate of $1.65. Revenue for the quarter came in at $716.6 million versus the consensus estimate of $691.67 million.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
- JPMorgan Starts Accton Technology Corp. (2345:TT) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
